site stats

Bluebird bio earnings

WebApr 13, 2024 · bluebird bio Inc ( BLUE) is up 3.23% today. BLUE has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on BLUE! BLUE stock closed at $2.79 and is up $0.09 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard … WebMar 31, 2024 · The consensus estimate for bluebird bio's current full-year earnings is ($4.29) per share. William Blair also issued estimates for bluebird bio's Q3 2024 earnings at ($0.74) EPS and Q4 2024 earnings at ($0.73) EPS. Several other equities research analysts also recently weighed in on the stock. Bank of America cut their target price on …

Bluebird Bio salaries: How much does Bluebird Bio pay? - Indeed

Web23 hours ago · Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. WebFeb 23, 2024 · bluebird bio (NASDAQ:BLUE) Q4 2024 results missed analyst estimates on both EPS and revenue.; Revenue increased modestly quarter over quarter from $10M to $10M and the EPS loss narrowed to ($3.01 ... five boroughs rosalie https://phillybassdent.com

investors & media - bluebird bio, Inc.

WebMar 22, 2024 · bluebird bio ( NASDAQ:BLUE - Get Rating) will be announcing its earnings results before the market opens on Wednesday, March 29th. Analysts expect the company to announce earnings of ($0.45) per share for the quarter. bluebird bio Stock Up 2.9 % NASDAQ:BLUE opened at $4.60 on Wednesday. WebFeb 24, 2024 · For Bluebird, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has... WebMar 27, 2024 · bluebird bio, Inc. ( NASDAQ:BLUE - Get Rating) - Investment analysts at William Blair issued their FY2024 earnings per share (EPS) estimates for shares of bluebird bio in a report released on Wednesday, March 22nd. William Blair analyst S. Corwin forecasts that the biotechnology company will post earnings of ($4.73) per share … canine rehab granby ct

Bluebird Bio (BLUE) May Report Negative Earnings: Know the …

Category:Nasdaq Surges 100 Points; US Producer Prices Drop In …

Tags:Bluebird bio earnings

Bluebird bio earnings

BLUE Earnings Date 2024 bluebird bio Earnings Forecast

Web1 day ago · The MarketWatch News Department was not involved in the creation of this content. Apr 13, 2024 (The Expresswire) -- New Research Report 2024: “ Sickle Cell Disease Treatment Market ” research ... WebFeb 9, 2024 · Bluebird Bio (BLUE) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Bluebird bio earnings

Did you know?

Web23 hours ago · Earnings Financial Advisors Markets. CRSP. Why Shares of CRISPR Therapeutics Jumped Thursday April 13, 2024 — 11:58 am EDT ... (another gene-editing SCD therapy developed by Bluebird Bio) would ... WebMar 29, 2024 · Bluebird Bio Inc. BLUE. shares are plummeting after the company signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. In early March, the company ...

WebMar 28, 2024 · Analysts estimate that bluebird bio will report an earnings per share (EPS) of $-0.60. bluebird bio bulls will hope to hear the company announce they've not only … WebMar 28, 2024 · This article bluebird bio Earnings Preview originally appeared on Benzinga.com.Read more on 'Benzinga'

Web1 day ago · bluebird bio, Inc. (NASDAQ:BLUE) Bluebird Bio signaled a delay in its sickle cell disease drug application to the FDA in its Q4 earnings release. The company’s stock has a 52-week low of $2.78. WebAug 4, 2024 · Bluebird Bio (BLUE) came out with a quarterly loss of $1.29 per share versus the Zacks Consensus Estimate of a loss of $1.31. This compares to loss of $3.58 per share a year ago. These figures are ...

WebAug 9, 2024 · Bluebird Bio, Inc. (NASDAQ:NASDAQ:BLUE) Q2 2024 Earnings Conference Call August 9, 2024 8:00 AM ETCompany ParticipantsNick Leschly – Chief Executive OfficerElizabeth Pingpank – Direct...

WebApr 14, 2024 · With the market capitalization of bluebird bio Inc. currently standing at about $344.49 million, investors are eagerly awaiting this quarter’s results, scheduled for May 08, 2024 – May 12, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. five boroughs pizza des plaines ilWeb4 rows · Mar 29, 2024 · bluebird bio, Inc. is expected* to report earnings on 03/29/2024 before market open. The ... five bossWeb1 day ago · Adds bluebird bio's reference in the analysis, adds name of Vertex and CRISPR Therapeutics' therapy. April 12 (Reuters) - Vertex Pharmaceuticals Inc VRTX.O and CRISPR Therapeutics AG's CRSP.BN one ... canine reflexology chart